title: Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression.
authors.forename: S
authors.initials: S
authors.lastname: Bomken
authors.forename: L
authors.initials: L
authors.lastname: Buechler
authors.forename: K
authors.initials: K
authors.lastname: Rehe
authors.forename: F
authors.initials: F
authors.lastname: Ponthan
authors.forename: A
authors.initials: A
authors.lastname: Elder
authors.forename: H
authors.initials: H
authors.lastname: Blair
authors.forename: C M
authors.initials: CM
authors.lastname: Bacon
authors.forename: J
authors.initials: J
authors.lastname: Vormoor
authors.forename: O
authors.initials: O
authors.lastname: Heidenreich
mesh_terms: D000818:Animals; D058948:Cell Tracking; D018450:Disease Progression; D005434:Flow Cytometry; D005822:Genetic Vectors; D049452:Green Fluorescent Proteins / Q000032:analysis* / Q000235:genetics; D006801:Humans; D016086:Lentivirus / Q000235:genetics*; D008156:Luciferases / Q000032:analysis* / Q000235:genetics; D051379:Mice; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000473:pathology*
chemical_list: C485184:enhanced green fluorescent protein; D049452:Green Fluorescent Proteins; D008156:Luciferases